0001140361-11-021199.txt : 20110406 0001140361-11-021199.hdr.sgml : 20110406 20110406213402 ACCESSION NUMBER: 0001140361-11-021199 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110404 FILED AS OF DATE: 20110406 DATE AS OF CHANGE: 20110406 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zhang Ian CENTRAL INDEX KEY: 0001500329 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33650 FILM NUMBER: 11744531 MAIL ADDRESS: STREET 1: C/O NEOSTEM, INC. STREET 2: 420 LEXINGTON AVENUE, SUITE 450 CITY: NEW YORK STATE: NY ZIP: 10170 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeoStem, Inc. CENTRAL INDEX KEY: 0000320017 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 222343568 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 450 CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 212-584-4171 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 450 CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: PHASE III MEDICAL INC/DE DATE OF NAME CHANGE: 20030819 FORMER COMPANY: FORMER CONFORMED NAME: CORNICHE GROUP INC /DE DATE OF NAME CHANGE: 19951117 FORMER COMPANY: FORMER CONFORMED NAME: FIDELITY MEDICAL INC DATE OF NAME CHANGE: 19951025 4 1 doc1.xml FORM 4 X0303 4 2011-04-04 0 0000320017 NeoStem, Inc. NBS 0001500329 Zhang Ian C/O NEOSTEM, INC. 420 LEXINGTON AVENUE, SUITE 450 NEW YORK NY 10170 0 1 0 0 See Remarks Stock Options (right to buy) 1.74 2011-04-04 4 A 0 250000 0 A 2021-04-03 Common Stock, par value $0.001 per share 250000 250000 D On April 4, 2011, the reporting person was granted a stock option to purchase 250,000 shares of Common Stock, pursuant and subject to the terms and conditions of the 2009 Non-U.S. Plan. This stock option is scheduled to vest as to 125,000 shares on each of October 4, 2011 and April 4, 2012. The option is subject to all of the terms and conditions of the 2009 Non-U.S. Plan. President and Managing Director, NeoStem (China), Inc. Ian Zhang, By: /s/ Catherine M. Vaczy, Esq., Attorney-in-Fact 2011-04-06